The Enterprise Value as of December 2025 (TTM) for InnoCare Pharma Limited (9969.HK) is 12.08B

According to InnoCare Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 12.08B. This represents a change of -4.39% compared to the average of 12.63B of the last 4 quarters.

InnoCare Pharma Limited (9969.HK) Historical Enterprise Value (quarterly & annually)

How has 9969.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of InnoCare Pharma Limited over the last ten years is 8.71B. The current 12.08B Enterprise Value has changed 13.77% with respect to the historical average. Over the past ten years (40 quarters), 9969.HK's Enterprise Value was at its highest in in the September 2025 quarter at 27.37B. The Enterprise Value was at its lowest in in the March 2024 quarter at -175886540.87.

InnoCare Pharma Limited (9969.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of InnoCare Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InnoCare Pharma Limited (9969.HK) Average Enterprise Value

How has 9969.HK Enterprise Value performed in the past?

The current Enterprise Value of InnoCare Pharma Limited (9969.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

InnoCare Pharma Limited (9969.HK) Enterprise Value vs. Peers

How is 9969.HK’s Enterprise Value compared to its peers?

InnoCare Pharma Limited’s Enterprise Value is greater than Zai Lab Limited (1.42B), less than Keymed Biosciences Inc. (14.26B), less than Ascentage Pharma Group International (18.90B), less than Everest Medicines Limited (14.80B), greater than MicroPort Scientific Corporation (3.58B), greater than HUTCHMED (China) Limited (1.01B), less than Duality Biotherapeutics, Inc. (21.64B), less than Guangzhou Innogen Pharmaceutl Grp Co Ltd (13.63B), less than Shanghai Conant Optical Co., Ltd. (21.95B), greater than Alphamab Oncology (8.81B),

Build a custom stock screener for InnoCare Pharma Limited (9969.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoCare Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InnoCare Pharma Limited (9969.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InnoCare Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.